7AVZ

MerTK kinase domain in complex with a bisaminopyrimidine inhibitor

7AVZ の概要

• エントリーDOI: 10.2210/pdb7avz/pdb
• 分子名称: Tyrosine-protein kinase Mer, (R)-N2-(4-(cyclopropylmethoxy)-3,5-difluorophenyl)-5-(3-methylpiperazin-1-yl)-N4-(tetrahydro-2H-pyran-4-yl)pyrimidine-2,4-diamine (3 entities in total)
• 機能のキーワード: tyrosine kinase, inhibitor, type3 kinase inhibitor, structure-based drug design, oncology, signaling protein
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 34856.30

構造登録者

Pflug, A.,Nissink, J.W.M.,Blackett, C.,Goldberg, K.,Hennessy, E.J.,Hardaker, E.,McCoull, W.,McMurray, L.,Collingwood, O.,Overman, R.,Preston, M.,Rawlins, P.,Rivers, E.,Schimpl, M.,Smith, P.,Underwood, E.,Truman, C.,Warwicker, J.,Winter, J.,Woodcock, S. (登録日: 2020-11-06, 公開日: 2021-03-03, 最終更新日: 2024-05-01)

• 主引用文献: Nissink, J.W.M.,Bazzaz, S.,Blackett, C.,Clark, M.A.,Collingwood, O.,Disch, J.S.,Gikunju, D.,Goldberg, K.,Guilinger, J.P.,Hardaker, E.,Hennessy, E.J.,Jetson, R.,Keefe, A.D.,McCoull, W.,McMurray, L.,Olszewski, A.,Overman, R.,Pflug, A.,Preston, M.,Rawlins, P.B.,Rivers, E.,Schimpl, M.,Smith, P.,Truman, C.,Underwood, E.,Warwicker, J.,Winter-Holt, J.,Woodcock, S.,Zhang, Y.; Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy.; J.Med.Chem., 64:3165-3184, 2021; PubMed: 33683117; DOI: 10.1021/acs.jmedchem.0c01904

実験手法

X-RAY DIFFRACTION (2.04 Å)